In the United States, buprenorphine products (namely buprenorphine/naloxone combination) and methadone are the primary forms of medication-assisted treatment (MAT) that are authorized for addressing opioid addiction. Although treatment ideologies differentiate MAT programs, much of the provision in the US reflects a model of “high threshold, low tolerance.” This model is discussed with a focus on structural and programmatic barriers that shape access to and retention in MAT. The critique continues with a discussion of multifaceted stigma that reinforces spoiled identities and diffuses into treatment settings. The social control mechanisms that are imposed in MAT are strikingly similar to those reflected in criminal justice settings, namely probation, parole and community corrections more generally. Parallels are drawn between the “addict” and the “felon” and how they are monitored, tracked, and controlled. These factors have major implications for recovery.
This study uses routine activity theory to examine violent and property crime victimization among a sample of 308 injection drug users (IDUs). We estimate prevalence rates and identify factors that contribute to the victimization of IDUs. The findings suggest that victimization rates of IDUs were much higher than rates found for the general urban population. Generally, crime involvement did not contribute significantly to victimization risk. Use of crack-cocaine increased the likelihood of property crime victimization whereas heroin use decreased the probability of both violent and property crime victimization. Other drug lifestyle activities (i.e., waiting in uncomfortable situations to buy drugs) also affected victimization risk Finally, the results suggest that victimization differed by age and by gender, despite controls for drug use and drug lifestyle activities. Explanations for these results are offered.
Several countries are experiencing public health crises as a result of opioid addiction. Fatal overdoses have reached record highs in many regions and Hepatitis C virus is the norm among people who inject drugs in several countries. Thus, providing for the global availability of medication-assisted treatment (MAT) for opioid addiction is more important than ever. In this article, we introduce readers to the collection of papers that appear in this special issue on MAT for opioid addiction. We describe the articles and commentaries thematically to include topics that address 1) the contemporary history of methadone maintenance, 2) the provision of and access and barriers to MAT, 3) compliance and outcomes of MAT, 4) health issues among MAT patients, 5) race, ethnicity, and social class backgrounds of MAT patients, 6) criminalization and stigma, and 7) challenges associated with the expansion of MAT.
Slightly more than half of admissions to U.S. publicly-funded treatment for marijuana use are referred by the criminal justice system; this pattern has remained for at least 20 years. Nationally, Blacks comprise nearly a third of treatment admissions for marijuana use. This article explores the interplay between race and criminal justice referrals to treatment for marijuana use. Using data from the (U.S.) 2011 Treatment Episode Data Set, we examine the relationship between race and diagnosis of cannabis use disorder (dependence versus abuse) among referrals to community-based treatment in North Carolina. We compare Black/White differences in cannabis diagnoses across four referral sources: the criminal justice system, healthcare providers, self, and other sources. Race was significantly related to type of diagnosis across all four referral sources, however, the nature of the relationship was distinctly different among criminal justice referrals with Whites being more likely than Blacks to be diagnosed with cannabis dependence. Moreover, the marijuana use profiles of criminal justice referrals differed substantially from individuals referred by other sources. The findings suggest that diagnoses of cannabis abuse (rather than dependence) may have worked to widen the diagnostic net by “capturing” individuals under control of the criminal justice system who manifested few problems with marijuana use, other than their involvement in the criminal justice system. The potential for a net-widening effect appeared to be most pronounced for Blacks.
19 February 2016 in Journal of Racial and Ethnic Health Disparities
Primary/secondary/tertiary prevention refers to a broad range of interventions that aim to prevent people from starting to use drugs, encourages drug users to stop, or aims to reduce harm once drug use has started. Primary drug prevention aims to discourage people, particularly children and young adults, from starting to use drugs. Secondary drug prevention chiefly aims to encourage those already using drugs to stop, to reduce their use, or to use more safely (see also 26 harm reduction). Tertiary drug prevention involves the treatment of the drug user, usually with the eventual goal of user abstinence, although interventions may also aim to reduce the negative impact of dependent drug use. Prevention differs from drug enforcement activities such ...